Kevin Rakin
CIK 1184421 · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AZYO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WESTPORT, CT 06880
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELUT | Director | 518,539 | $0.80 | $413.8K | $296.8K | 6 | 2026-06-15 |
| QSI | Director | 1,220,512 | $1.46 | $1.78M | -$191.2K | 8 | 2026-05-20 |
| ORMP | Director | 46,661 | $4.08 | $190.4K | -$536.9K | 17 | 2022-03-22 |
| ELUTIA INC. (AZYO) Delisted | Director | 4,062,451 | $1.49 | $6.05M | $75.00M | 1 | 2020-10-13 |
| Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Director | 6,000 | — | — | $27.3K | 4 | 2008-09-05 |
| VION PHARMACEUTICALS INC (VION) Delisted | Director | 6,100 | — | — | $23.9K | 3 | 2007-06-28 |
Recent Filings · Page 3 of 5
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-02 | ORMP | Grant (A) | +10,000 | $0 | EDGAR |
| 2021-08-11 | ORMP | Mixed | +53,043 | $14 | EDGAR |
| 2021-06-15 | QSI | Grant (A) | +1,921,512 | $19.01M | EDGAR |
| 2021-02-17 | ORMP | Grant (A) | — | $0 | EDGAR |
| 2020-10-13 | ELUTIA INC. (AZYO) Delisted | Mixed | +45,088,310 | $75.28M | EDGAR |
| 2020-01-14 | ORMP | Grant (A) | — | $0 | EDGAR |
| 2019-09-16 | ORMP | Mixed | — | $0 | EDGAR |
| 2019-04-12 | ORMP | Grant (A) | — | $0 | EDGAR |
| 2019-02-11 | — | Exer (M) | +350,853 | $0 | |
| 2018-10-11 | — | Buy (P) | +230,768 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.